Comparison of orally administered bisphosphonate drugs in reducing the risk of hip fracture in older adults: a population-based cohort study

BACKGROUND: Orally administered bisphosphonate drugs (i.e., alendronate, etidronate, risedronate) can reduce the risk of vertebral fracture. However, only alendronate and risedronate have proven efficacy in reducing the risk of hip fracture. We sought to examine the comparative effectiveness of oral...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Cadarette, Suzanne M., Lévesque, Linda, Mamdani, Muhammad, Perreault, Sylvie, Juurlink, David N., Paterson, J. Michael, Carney, Greg, Gunraj, Nadia, Hawker, Gillian A., Tadrous, Mina, Wong, Lindsay, Dormuth, Colin R.
Format: Artigo
Jezik:Inglês
Izdano: Canadian Medical Association 2013
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3986012/
https://ncbi.nlm.nih.gov/pubmed/25077113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20130036
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items